Stratos Wealth Partners, Ltd. Charles River Laboratories International, Inc. Transaction History

Stratos Wealth Partners, Ltd.

$6.9 Billion
Q4 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 1,523 shares of CRL stock, worth $249,452. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,523

Previous 1,837 17.09%

Holding current value

$249,452

Previous $361,000 22.16%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$178.58 - $220.69 $56,074 - $69,296	-314 Reduced 17.09%	1,523 $281,000
Q3 2024 Oct 17, 2024	SELL	$187.96 - $245.29 $65,410 - $85,360	-348 Reduced 15.93%	1,837 $361,000
Q2 2024 Jul 24, 2024	BUY	$206.39 - $268.73 $48,914 - $63,689	237 Added 12.17%	2,185 $451,000
Q1 2024 Apr 16, 2024	SELL	$203.52 - $273.43 $97,486 - $130,972	-479 Reduced 19.74%	1,948 $527,000
Q4 2023 Jan 24, 2024	SELL	$164.52 - $238.84 $12,832 - $18,629	-78 Reduced 3.11%	2,427 $573,000
Q3 2023 Oct 24, 2023	BUY	$194.44 - $217.61 $95,858 - $107,281	493 Added 24.5%	2,505 $490,000
Q2 2023 Jul 18, 2023	BUY	$183.71 - $210.25 $22,596 - $25,860	123 Added 6.51%	2,012 $423,000
Q1 2023 Apr 27, 2023	SELL	$191.89 - $259.92 $46,053 - $62,380	-240 Reduced 11.27%	1,889 $381,000
Q4 2022 Jan 19, 2023	SELL	$197.11 - $250.07 $11,826 - $15,004	-60 Reduced 2.74%	2,129 $0
Q3 2022 Oct 24, 2022	SELL	$182.44 - $250.54 $27,730 - $38,082	-152 Reduced 6.49%	2,189 $431,000
Q2 2022 Jul 22, 2022	SELL	$204.13 - $302.4 $32,456 - $48,081	-159 Reduced 6.36%	2,341 $501,000
Q1 2022 Apr 26, 2022	BUY	$255.51 - $362.11 $44,714 - $63,369	175 Added 7.53%	2,500 $710,000
Q4 2021 Jan 14, 2022	SELL	$351.38 - $448.68 $62,545 - $79,865	-178 Reduced 7.11%	2,325 $876,000
Q3 2021 Oct 19, 2021	BUY	$372.64 - $458.3 $132,287 - $162,696	355 Added 16.53%	2,503 $1.03 Million
Q1 2021 Apr 27, 2021	BUY	$249.67 - $299.48 $26,964 - $32,343	108 Added 5.29%	2,148 $623,000
Q4 2020 Jan 29, 2021	SELL	$222.0 - $252.62 $9,546 - $10,862	-43 Reduced 2.06%	2,040 $510,000
Q3 2020 Oct 29, 2020	SELL	$175.56 - $226.45 $7,022 - $9,058	-40 Reduced 1.88%	2,083 $472,000
Q2 2020 Jul 28, 2020	BUY	$118.84 - $189.72 $9,863 - $15,746	83 Added 4.07%	2,123 $370,000
Q4 2019 Jan 29, 2020	BUY	$126.05 - $152.76 $6,302 - $7,638	50 Added 2.51%	2,040 $312,000
Q3 2019 Nov 12, 2019	BUY	$125.07 - $143.67 $248,263 - $285,184	1,985 Added 39700.0%	1,990 $263,000
Q3 2019 Nov 12, 2019	SELL	$125.07 - $143.67 $248,263 - $285,184	-1,985 Reduced 99.75%	5 $266,000
Q3 2018 Nov 02, 2018	BUY	$112.11 - $134.54 $21,300 - $25,562	190 Added 10.56%	1,990 $268,000
Q1 2018 May 10, 2018	SELL	$98.19 - $115.2 $1,080 - $1,267	-11 Reduced 0.61%	1,800 $192,000
Q4 2017 Feb 09, 2018	BUY	$100.43 - $118.09 $181,878 - $213,860	1,811	1,811 $198,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

51.8M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Charles River Laboratories International, Inc. Transaction History